A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's disease
Identifieur interne : 001980 ( Istex/Curation ); précédent : 001979; suivant : 001981A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's disease
Auteurs : Richard B. Dewey Jr [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Joseph Y. Matsumoto [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1998-09.
English descriptors
- KwdEn :
Abstract
Nine patients with advanced levodopa‐responsive Parkinson's disease were enrolled in a double‐blind, placebocontrolled crossover trial of intranasal apomorphine as rescue therapy for parkinsonian off‐states. Patients were assigned in random order to each of four possible combinations of apomorphine, trimethobenzamide antiemetic, and their matched placebos and received detailed in‐office motor scoring during each of the four study periods. Patients also completed diaries describing the effectiveness of the nasal spray for reversing off‐states. A statistically significant reduction in the Unified Parkinson's Disease Rating Scale (UPDRS) motor score was seen following active apomorphine during in‐office evaluation visits but not following placebo nasal spray. Patient diaries revealed that active apomorphine had a latency to onset of 11 minutes and a duration of 50 minutes. Significant nausea from apomorphine spray was seen in only one patient whereas nasal irritation was disabling in three and mild in two. We conclude that intranasal apomorphine is an effective rescue agent for parkinsonian off‐states although nasal irritation is a limiting factor.
Url:
DOI: 10.1002/mds.870130505
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001980
Links to Exploration step
ISTEX:482B278A5C9A850940ADEAFABE2AFF14E8EDE42DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's disease</title>
<author><name sortKey="Dewey Jr, Richard B" sort="Dewey Jr, Richard B" uniqKey="Dewey Jr R" first="Richard B." last="Dewey Jr">Richard B. Dewey Jr</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Texas Southwestern Medical School, Dallas, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of Texas Southwestern Medical School, Dallas</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Matsumoto, Joseph Y" sort="Matsumoto, Joseph Y" uniqKey="Matsumoto J" first="Joseph Y." last="Matsumoto">Joseph Y. Matsumoto</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:482B278A5C9A850940ADEAFABE2AFF14E8EDE42D</idno>
<date when="1998" year="1998">1998</date>
<idno type="doi">10.1002/mds.870130505</idno>
<idno type="url">https://api.istex.fr/document/482B278A5C9A850940ADEAFABE2AFF14E8EDE42D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001980</idno>
<idno type="wicri:Area/Istex/Curation">001980</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's disease</title>
<author><name sortKey="Dewey Jr, Richard B" sort="Dewey Jr, Richard B" uniqKey="Dewey Jr R" first="Richard B." last="Dewey Jr">Richard B. Dewey Jr</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, University of Texas Southwestern Medical School, Dallas, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, University of Texas Southwestern Medical School, Dallas</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Maraganore, Demetrius M" sort="Maraganore, Demetrius M" uniqKey="Maraganore D" first="Demetrius M." last="Maraganore">Demetrius M. Maraganore</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ahlskog, J Eric" sort="Ahlskog, J Eric" uniqKey="Ahlskog J" first="J. Eric" last="Ahlskog">J. Eric Ahlskog</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Matsumoto, Joseph Y" sort="Matsumoto, Joseph Y" uniqKey="Matsumoto J" first="Joseph Y." last="Matsumoto">Joseph Y. Matsumoto</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Neurology, Mayo Clinic, Rochester, Minnesota, U.S.A.</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Mayo Clinic, Rochester, Minnesota</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1998-09">1998-09</date>
<biblScope unit="vol">13</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="782">782</biblScope>
<biblScope unit="page" to="787">787</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">482B278A5C9A850940ADEAFABE2AFF14E8EDE42D</idno>
<idno type="DOI">10.1002/mds.870130505</idno>
<idno type="ArticleID">MDS870130505</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Apomorphine</term>
<term>Intranasal</term>
<term>Motor fluctuations</term>
<term>Parkinson's disease</term>
<term>Rescue</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Nine patients with advanced levodopa‐responsive Parkinson's disease were enrolled in a double‐blind, placebocontrolled crossover trial of intranasal apomorphine as rescue therapy for parkinsonian off‐states. Patients were assigned in random order to each of four possible combinations of apomorphine, trimethobenzamide antiemetic, and their matched placebos and received detailed in‐office motor scoring during each of the four study periods. Patients also completed diaries describing the effectiveness of the nasal spray for reversing off‐states. A statistically significant reduction in the Unified Parkinson's Disease Rating Scale (UPDRS) motor score was seen following active apomorphine during in‐office evaluation visits but not following placebo nasal spray. Patient diaries revealed that active apomorphine had a latency to onset of 11 minutes and a duration of 50 minutes. Significant nausea from apomorphine spray was seen in only one patient whereas nasal irritation was disabling in three and mild in two. We conclude that intranasal apomorphine is an effective rescue agent for parkinsonian off‐states although nasal irritation is a limiting factor.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001980 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001980 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:482B278A5C9A850940ADEAFABE2AFF14E8EDE42D |texte= A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |